Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML

Clinical trial NCT07617285 · RECRUITING

Trial details

NCT number: NCT07617285
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

AML Refractory/Relapse Acute Myeloid Leukemia

Start date: 2026-05-07
Primary completion: 2027-12-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.